Browse Title Index

Issue Title
Vol 16, No 5 (2009) 131-Iodine Tositumomab in lymphoma Abstract   PDF
M.C. Cheung, J.A. MacEachern, A.E. Haynes, R.M. Meyer, K. Imrie, and the Members of the Hematology Disease Site Group of the Cancer Care Ontario Program in Evidence-Based Care
Vol 21, No 4 (2014) 18F-Fluorodeoxyglucose positronemission tomography could have a prognostic role in patients with advanced hepatocellular carcinoma Abstract   PDF   HTML
E. Simoneau, M. Hassanain, A. Madkhali, A. Salman, C.G. Nudo, P. Chaudhury, P. Metrakos
Vol 19, No 1 (2012) A call for action in survivorship research and care Abstract   PDF   HTML
R. Doll, A. Kazanjian, K. Smillie, A. Ward, M. Chasen
Vol 21, No 5 (2014) A Canadian consensus on the management of newly diagnosed and relapsed acute promyelocytic leukemia in adults Abstract   PDF   HTML
M.D. Seftel, M.J. Barnett, S. Couban, B. Leber, J. Storring, W. Assaily, B. Fuerth, A. Christofides, A.C. Schuh
Vol 18, No 2 (2011) A Canadian economic analysis of U.S. Oncology Adjuvant Trial 9735 Abstract   PDF   HTML
L. Bernard, S. Verma, M. F. Thompson, B. C.F. Chan, N. Mittmann, L. Asma, S. E. Jones
Vol 19, No 3 (2012) A Canadian perspective on bendamustine for the treatment of chronic lymphocytic leukemia and non-Hodgkin lymphoma Abstract   PDF   HTML
R. Van der Jagt, P. Laneuville, D. MacDonald, D. Stewart, A. Christofides, L.H. Sehn
Vol 21, No 1 (2014) A Canadian perspective on the safe administration of bendamustine and the prevention and management of adverse events Abstract   PDF   HTML   Corrigendum
J. Koolwine, T. Crosbie, G. Gazzé, R. Turner, J. Wiernikowski, W. Assaily
Vol 17, No 4 (2010) A case for tobacco content regulation by the U.S. Food and Drug Administration Abstract   PDF
J.A. du Toit
Vol 18, No 1 (2011) A comparative analysis of monthly out-of-pocket costs for patients with breast cancer as compared with other common cancers in Ontario, Canada Abstract   PDF   HTML
C. J. Longo, B. G. Bereza
Vol 20, No 3 (2013) A comparison of patient knowledge of clinical trials and trialist priorities Abstract   PDF   HTML
P. Cameron, G.R. Pond, R.Y. Xu, P.M. Ellis, J.R. Goffin
Vol 21, No 3 (2014) A comparison of the risks of in-breast recurrence after a diagnosis of DCIS or early invasive breast cancer Abstract   PDF   HTML
S.A. Narod, E. Rakovitch
Vol 13, No 2 (2006) A Comparison of the Sensitivity of Intensity Modulated and Three-Dimensional Conformal Radiation Therapy Plans for Oropharyngeal Cancer to Set-Up Errors and Uncertainties Details   PDF
Nicolas Paul Ploquin
Vol 18, No 4 (2011) A comprehensive bone health management approach for men with prostate cancer receiving androgen deprivation therapy Abstract   PDF   HTML
C.E. Lee, W.D. Leslie, P. Czaykowski, J. Gingerich, M. Geirnaert, Y.K.J. Lau
Vol 19, No 5 (2012) A first look at participation rates in cervical cancer screening programs in Canada Details   PDF   HTML   CORRIGENDUM
T. Forte, G.A. Lockwood, C.M. McLachlin, S. Fekete, H. Bryant
Vol 16, No 1 (2009) A Framework for the Organization and Delivery of Systemic Treatment Abstract   PDF
Ted Vandenberg, Nadia Coakley, Jeff Naylor, Cathy DeGrasse, Esther Green, Jean A Mackay, Cynthia McLennan, Anne Smith, Laura Wilcock, Maureen E Trudeau
Vol 18, No 5 (2011) A legal right to die: responding to slippery slope and abuse arguments Details   PDF   HTML
D. Benatar
Vol 19, No 2 (2012) A mixed-methods cohort study to determine perceived patient benefit in providing custom breast prostheses Abstract   PDF   HTML
T.M. Kubon, J. McClennen, M.I. Fitch, A. McAndrew, J. Anderson
Vol 19, No 1 (2012) A model for breast cancer risk based on stem-cell theory Abstract   PDF   HTML
S. A. Narod
Vol 18, No 3 (2011) A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain Abstract   PDF   HTML
N. A. Hagen, B. Lapointe, M. Ong-Lam, B. Dubuc, D. Walde, B. Gagnon, R. Love, R. Goel, P. Hawley, A. Ho Ngoc, P. du Souich
Vol 18, No 2 (2011) A new standard of care for the management of peritoneal surface malignancy Abstract   PDF   HTML
F. Mohamed, T. Cecil, B. Moran, P. Sugarbaker
Vol 20, No 3 (2013) A pan-Canadian practice guideline and algorithm: screening, assessment, and supportive care of adults with cancer-related fatigue Abstract   PDF   HTML
D. Howell, S. Keller-Olaman, T.K. Oliver, T.F. Hack, L. Broadfield, K. Biggs, J. Chung, D. Gravelle, E. Green, M. Hamel, T. Harth, P. Johnston, D. McLeod, N. Swinton, A. Syme, K. Olson
Vol 19, No 2 (2012) A personalized approach to treatment: use of egfr tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer in Canada Abstract   PDF   HTML   CORRIGENDUM
V. Hirsh, B. Melosky, G. Goss, D. Morris, W. Morzycki
Vol 20, No 3 (2013) A pilot study examining the unmet needs of cancer survivors living with polypathology Abstract   PDF   HTML
M. Siu, P. Catton, J. Jones, A.R. Jadad
Going Beyond Efficacy A Primer of Bone Metastases Management in Breast Cancer Patients Abstract   PDF
Mark Clemons, Bianca Petrut, Mateya Trinkaus, Christine Simmons
Vol 21, No 2 (2014) A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers Abstract   PDF   HTML
S.A. Narod, N. Tung, J. Lubinski, T. Huzarski, M. Robson, H.T. Lynch, S.L. Neuhausen, P. Ghadirian, C. Kim–Sing, P. Sun, W.D. Foulkes, The Hereditary Breast Cancer Clinical Study Group
Vol 20, No 6 (2013) A prospective evaluation of an interdisciplinary nutrition–rehabilitation program for patients with advanced cancer Abstract   PDF   HTML
B. Gagnon, J. Murphy, M. Eades, J. Lemoignan, M. Jelowicki, S. Carney, S. Amdouni, P. Di Dio, M. Chasen, N. MacDonald
Vol 18, No 6 (2011) A prospective pilot study investigating the musculoskeletal pain in postmenopausal breast cancer patients receiving aromatase inhibitor therapy Abstract   PDF   HTML
A. Robidoux, E. Rich, N.J. Bureau, S. Mader, D. Laperrière, M. Bail, N. Tremblay, J. Turgeon, M. Patenaude
Vol 17, No 5 (2010) A rare adverse skin reaction after 8 Gy of radiation therapy to the thoracic spine: case report and review of the literature Abstract   PDF
G. Mitera, G. Chan, K. Mah, R. Law, C. DeAngelis, R. Dent, E. Chow
Vol 20, No 2 (2013) A real-life experience using panitumumab in chemo-refractory metastatic colorectal cancer patients: a retrospective analysis at the Jewish General Hospital, 2009-2012 Abstract   PDF   HTML
A. Mamo, M. Cardoso Nogueira, G. Batist, M. Palumbo, L. Panasci, C. Ferrario, P. Chaudhury, P. Metrakos, P. Kavan
Vol 19, No 6 (2012) A retrospective chart review validates indicator results and provides insight into reasons for non-concordance with evidence-based guidelines Abstract   PDF   HTML
J. Klein–Geltink, T. Forte, R. Rahal, J. Niu, D. He, G. Lockwood, W. Cheung, G. Darling, H. Bryant
Vol 17, No 2 (2010) A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital Abstract   PDF
S. N. Chin, L. Wang, M. Moore, S. S. Sridhar
Vol 16, No 1 (2009) A Review of the Reliability and Validity of the Edmonton Symptom Assessment System Abstract   PDF
Lyndsay A Richardson, Glenn W Jones
Vol 18, No 4 (2011) A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis Abstract   PDF   HTML
C. Hamm, M. El-Masri, G. Poliquin, V. Poliquin, J. Mathews, S. Kanjeekal, Y. Alam, S. Kulkarni, T. Elfiki
Vol 21, No 4 (2014) A systematic review of active treatment options in patients with desmoid tumours Abstract   PDF   HTML
X. Yao, T. Corbett, A. Gupta, R.A. Kandel, S. Verma, J. Werier, M. Ghert
Vol 19, No 6 (2012) A systematic review of integrative oncology programs Abstract   PDF   HTML
D.M. Seely, L.C. Weeks, S. Young
Vol 14, No 2 (2007) A Tale of Two Time Periods: Ovarian Cancer Trends in Ontario Abstract   PDF
Laurie M Elit, Susan J Bondy, Zhongliang Chen, Lawrence Paszat
Vol 19, No 2 (2012) Accelerating knowledge to action: the pan-Canadian cancer control strategy Abstract   PDF   HTML
L. Fairclough, J. Hill, H. Bryant, L. Kitchen-Clarke
Vol 21, No 3 (2014) Access to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatment Abstract   PDF   HTML
Y. Bombard, L. Rozmovits, M. Trudeau, N.B. Leighl, K. Deal, D.A. Marshall
Vol 12, No 4 (2005) Access to radiation therapy: modeling the geographic distribution of demand Details   PDF
Michael R Taylor, Peter S Craighead, Peter B Dunscombe
Vol 17, No 4 (2010) Access to thalidomide for the treatment of multiple myeloma in Canada: physician behaviours and ethical implications Abstract   PDF
L. Minuk, R. Sibbald, J. Peng, S. Bejaimal, I. Chin-Yee
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Active surveillance for prostate cancer: patient selection and management Abstract   PDF
L. Klotz
Vol 18, No 2 (2011) Acute aortic thrombosis in patients receiving cisplatin-based chemotherapy Abstract   PDF   HTML
D. D. Fernandes, M. L. Louzada, C. A. Souza, F. Matzinger
Vol 18, No 1 (2011) Acute liver failure because of chronic lymphocytic leukemia: case report and review of the literature Abstract   PDF   HTML
K. Esfahani, P. Gold, S. Wakil, R. P. Michel, S. Solymoss
Vol 14, No 2 (2007) Addition of Lenalidomide to Melphalan in the Treatment of Newly Diagnosed Multiple Myeloma: The NCIC CTG MY.11 Trial Details   PDF
Darrell White, Nancy Paul, David A Macdonald, Ralph M Meyer
Vol 19, No 5 (2012) Adenocarcinoma not otherwise specified on dorsum of tongue: case report and literature review Abstract   PDF   HTML
B.A. Market Velker, A.V. Louie, V.M. Velker, K.F. Kwan, J.H. Franklin, V.M. Venkatesan
Vol 20, No 6 (2013) Adenocarcinoma not otherwise specified or cribriform adenocarcinoma on dorsum of tongue? Abstract   PDF   HTML
S. Yang
Vol 22, No 1 (2015) Adherence to abiraterone among the first 86 recipients after release in Saskatchewan Abstract   PDF   HTML
A.D. Smith, C. Olson, B. Lyons, D. Tran, D. Blackburn
Vol 16 (2009): Renal Cell Carcinoma Supplement Adjuvant and Neoadjuvant Small Molecule Targeted Therapy Abstract   PDF
Anil Kapoor
Vol 21, No 4 (2014) Adjuvant and neoadjuvant treatment for rectal cancer, colon cancer, and non-small-cell lung cancer in older patients Abstract   PDF   HTML
R. Rahal, G. Porter, T. Forte, S. Fung, H. Bryant, the System Performance Steering Committee, the Technical Working Group
Vol 17, No 4 (2010) Adjuvant chemoradiation for gastric cancer with infusional 5-fluorouracil and cisplatin: a phase I study Abstract   PDF
Z. Kassam, H. Mackay, C.A. Buckley, S. Fung, M. Pintile, A. Oza, J. Brierley, C. Swallow, B. Cummings, J.J. Knox, J. Kim, R. Wong, L. Siu, R. Feld, J. Ringash
Vol 15, No 3 (2008) Adjuvant Hormonal Therapy for Stage I Endometrial Cancer Details   PDF
Lilian Gien, Janice S Kwon, Thomas K Oliver, Michael Fung-Kee-Fung
Vol 17, No 3 (2010) Adjuvant interferon alfa for melanoma Abstract   PDF
K. S. Wilson, A. Attwell
Vol 16, No 3 (2009) Adjuvant Interferon alfa for melanoma: new evidence-based treatment recommendations? Abstract   PDF
Axel Hauschild
Vol 13, No 1 (2006) Adjuvant trastuzumab: progress, controversies, and the steps ahead Details   PDF
John Mackey, Anil A Joy
Vol 19, No 2 (2012) Advances in the management of metastatic breast cancer: options beyond first-line chemotherapy Abstract   PDF   HTML
J.P.M. Ayoub, S. Verma, S. Verma
Vol 20, No 1 (2013) Advantages of exercise in breast cancer patients and survivors in addition to its mitigating effect on chest wall pain Details   PDF   HTML
S. Kapoor
Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer Abstract   PDF
M. Fakih, M. Vincent
Vol 21, No 1 (2014) Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis Abstract   PDF   HTML
I. Kong, S.A. Narod, C. Taylor, L. Paszat, R. Saskin, S. Nofech-Moses, D. Thiruchelvam, W. Hanna, J.P. Pignol, S. Sengupta, L. Elavathil, P.A. Jani, S.J. Done, S. Metcalfe, E. Rakovitch
Vol 14, No 3 (2007) Alemtuzumab in Chronic Lymphocytic Leukemia: A Systematic Review and Clinical Practice Guideline Details   PDF
Christopher A Smith
Vol 20, No 1 (2013) Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario Abstract   PDF   HTML
R. Ramjeesingh, R.M. Meyer, M. Brouwers, B.E. Chen, C.M. Booth
Vol 20, No 4 (2013) Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial Abstract   PDF   HTML
P. Haddad, F. Amouzgar-Hashemi, S. Samsami, S. Chinichian, M.A. Oghabian
Vol 19, No 2 (2012) Alternative and orthodox medicine and the “odd” principle Abstract   PDF   HTML
L.Z.G. Touyz
Vol 18, No 2 (2011) An appraisal of life’s terminal phases and euthanasia and the right to die Details   PDF   HTML
L. Z.G. Touyz, S. J.J. Touyz
Vol 15, No 2 (2008) An Approach to the Management of Chronic Myeloid Leukemia in British Columbia Details   PDF
Donna Lynn Forrest, X Jiang, C Eaves, C Smith
Jane Maher
Vol 20, No 6 (2013) An interprofessional palliative care oncology rehabilitation program: effects on function and predictors of program completion Abstract   PDF   HTML
M.R. Chasen, A. Feldstain, D. Gravelle, N. MacDonald, J. Pereira
Vol 16 (2009): Endocrine Therapy Update Supplement An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor–positive early breast cancer Abstract   PDF
S. Verma, S. Sehdev, A Joy, Y. Madarnas, J. Younus, J. A. Roy
Vol 15, No 5 (2008) Anal Cancer and Human Papillomaviruses in Heterosexual Men Abstract   PDF
Alan Nyitray
Vol 20, No 2 (2013) Analysis of intraprostatic therapeutic effects in prostate cancer patients using [11C]-choline PET/CT after external-beam radiation therapy Abstract   PDF   HTML
J. Amanie, H.S. Jans, M. Wuest, N. Pervez, A. Murtha, N. Usmani, D. Yee, R. Pearcey, B. Danielson, S. Patel, R. Macewan, C. Field, D. Robinson, J. Wilson, D. Lewis, M. Parliament, A.J.B. McEwan
Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective Androgen deprivation therapy for prostate cancer—review of indications in 2010 Abstract   PDF
H. Quon, D.A. Loblaw
Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care? Abstract   PDF   HTML
L. Klotz, P. Toren
Vol 14, No 6 (2007) Anemia is a common but neglected complication of adjuvant chemotherapy for early-stage breast cancer Details   PDF
Amanda Goldrick, Ivo A Olivotto, Cheryl Alexander, Caroline H Speers, Jeff Barnett, Sharon J Allan, Pauline T Truong
Vol 21, No 1 (2014) Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAFV600E-mutant metastatic colorectal carcinoma Abstract   PDF   HTML
K. Connolly, D. Brungs, E. Szeto, R.J. Epstein
Vol 17, No 4 (2010) Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme Abstract   PDF
J. Oh, G.J. Kutas, P. Davey, M. Morrison, J.R. Perry
Vol 17, No 1 (2010) Application of machine learning methodology for PET-based definition of lung cancer Abstract   PDF
A. Kerhet, C. Small, H. Quon, T. Riauka, L. Schrader, R. Greiner, D. Yee, A. McEwan, W. Roa
1 - 75 of 940 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Copyright © 2015 Multimed Inc.
ISSN: 1198-0052 (Print) ISSN: 1718-7729 (Online)